HIV I Infection: Clinical Trials

2 trials for HIV I Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow HIV I Infection: new trials by email Literature Review of HIV I Infection trials Research Report on HIV I Infection

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA
CAB + RPV - HIV-1-infection, HIV Infections
Phase 3CompletedAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)122023-01-012026-07-14
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
Immediate anti-TB therapy, Sepsis-specific dose anti-TB therapy - Tuberculosis, HIV I Infection
Phase 3CompletedUniversity of Virginia4372022-01-052026-09-09

Narrower conditions

HIV Infections (1)  ·  Sepsis (1)  ·  Tuberculosis (1)

Broader conditions

Infections (2)  ·  Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Inflammation (1)  ·  Lentivirus Infections (1)  ·  Mycobacterium Infections (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) (1)  ·  University of Virginia (1)

Countries

Tanzania (1)  ·  Uganda (1)  ·  United States (1)

Top investigators

Christopher Moore, MD (1)

Results publications

PMID 35667721, PMID 41619753, PMID 41768988

NIH funding

U01AI150508 (1)